Navigation Links
Althea Technologies Announces Appointment of Rick Hancock as President

SAN DIEGO, Nov. 11, 2010 /PRNewswire/ -- Althea Technologies, Inc., a leading provider of contract development and manufacturing services for biopharmaceutical and parenteral products, announced today that Rick Hancock has been appointed President of the company.  Mr. Hancock brings twenty-seven years of industry experience and detailed working knowledge of Althea's operations to lead the company into the future.  Mr. Hancock will lead the company's expansion of its clinical and commercial contract manufacturing services.



Dr. Magda Marquet, Co-Founder and Co-Chairman of the Board, commented, "I am very confident that Rick's proven track record and leadership style will be integral to Althea's growth and success as we continue to expand our business into commercial operations.  I am delighted to see Rick appointed as President."

Mr. Hancock was Althea's Chief Operating Officer from 1998 to 2007. In addition, he served as Althea's Executive Vice President, Europe to expand Althea's global presence. During his tenure as Althea's COO, Rick was instrumental in growing the company from a small group of scientists and manufacturing staff to a leading contract manufacturing organization.  In addition, Mr. Hancock has a very strong background in process development and GMP manufacturing dating back to his tenure at Hybritech, The Immune Response Corporation and Genetics Institute.

Commenting on the contributions of his predecessor, Mr. Hancock said, "I'm very appreciative for all the systems and improvements that Dr. Shabbir Anik put in place at Althea over the past two years.  His efforts have helped build an infrastructure that provides an excellent foundation for our anticipated growth and expansion."  

Matt Mackowski, Co-Chairman of the Board and Chairman of Telegraph Hill Partners, commented, "I am confident that Rick's strengths in building top-performing teams combined with Althea's technical depth and broad development and manufacturing capabilities will both delight our customers and build upon Althea's recognition as the West Coast's premier Biologics CMO."  

Mr. Hancock added, "I'm honored to work with such an experienced and qualified management team; we all look forward to continuing to provide our customers with outstanding services."

About Althea Technologies, Inc.

Althea Technologies is a fully integrated, contract development and manufacturing organization that provides services for plasmid DNA, recombinant proteins, and sterile products. Located in San Diego, CA, Althea offers cell banking, process development, cGMP protein & plasmid production, analytical development, formulation and lyophilization development, and aseptic filling in vials & prefilled syringes for clinical development and commercialization.  Althea's formulation technology platform employs crystalomics that can be applied to a variety of peptides and proteins for high concentration or sustained release formulations.  For more information, visit

SOURCE Althea Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Althea Technologies Adds Formulation Development to Its Integrated Offering of Contract Services
2. Althea Technologies Acquires Altus Pharmaceuticals(R) Assets and IP Portfolio, Establishing Technology Platform for Protein Formulations.
3. Althea Technologies Announces the Installation of a High-Speed Prefilled Syringe Line
4. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
5. King Pharmaceuticals and Palatin Technologies Delay Immediate Plans for Phase 3 Clinical Program With Bremelanotide for Erectile Dysfunction
6. Rockwell Medical Technologies, Inc. Begins Patient Enrollment for its SFP Dose-Ranging Study
7. Rockwell Medical Technologies, Inc. Begins Dosing Patients for SFP Phase IIb Clinical Study
8. New Clinical Studies Confirm Mauna Kea Technologies Cellvizio(R) GI in Range of Procedures
9. Palatin Technologies, Inc. Reports Initiation of Human Trials for the Treatment of Congestive Heart Failure
10. Emisphere Technologies, Inc. Announces 2007 Third Quarter Financial Results
11. Senesco Technologies Initiates Preclinical Studies for Cancer Target
Post Your Comments:
(Date:12/1/2015)... Russia has always been a country of choice for ... Europe in 2015 were tested in phase II-III ... has always been a country of choice for global multi-center phase ... in 2015 were tested in phase II-III clinical trials ... always been a country of choice for global multi-center phase III clinical ...
(Date:12/1/2015)... ANGELES , Dec. 1, 2015 CytRx ... development company specializing in oncology, today announced that it ... the company,s pivotal global Phase 3 clinical trial of ... (STS). Enrollment was originally estimated to be completed in Q1 ... being conducted under a Special Protocol Assessment from the ...
(Date:12/1/2015)... , Dec. 1, 2015  The migration to ... develop shared care plans that help patients stay ... plans will be digitally enabled, incorporate care guidelines ... and desires. They will also allow all stakeholders ... health journey is optimal. That is the vision, ...
Breaking Medicine Technology:
(Date:12/1/2015)... ... 01, 2015 , ... Physicians’ Education Resource®, LLC (PER®) ... announced that the first annual School of Gastrointestinal Oncology™ (SOGO™) will be held ... treatment of gastrointestinal cancers are undergoing transformational change, providing oncologists with powerful new ...
(Date:12/1/2015)... ... December 01, 2015 , ... Speech and ... believe that with innovative technologies and under the right circumstances, these practices can ... benefit of a dual-approach to his or her therapeutic sessions, as well as ...
(Date:12/1/2015)... , ... December 01, 2015 , ... ... the 7th Annual 2015 Golden Bridge Business Awards under the New Products and ... zero capex web based sample management software that helps labs organize ...
(Date:12/1/2015)... ... December 01, 2015 , ... The importance of volumetric ... the focus of numerous abstracts accepted for presentation here, at the 101st Annual ... abstracts highlight the use of Volpara Solutions’ quantitative breast imaging software tools for ...
(Date:12/1/2015)... ... December 01, 2015 , ... SAN FRANCISCO, Calif. ... that the organization has awarded Education and Developmental Therapies (EDT), an Applied Behavior ... award celebrates exceptional special needs providers that excel in synthesizing the areas of ...
Breaking Medicine News(10 mins):